John Peck
Direktor/Vorstandsmitglied bei Batu Biologics, Inc.
Vermögen: 227 283 $ am 30.04.2024
Profil
John Peck is currently a Director at Batu Biologics, Inc. He holds an MBA from DePaul University and an undergraduate degree from Northern Illinois University, which he received in 1996.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2023 | 227 283 333 ( 5,37% ) | 227 283 $ | 30.04.2024 |
Aktive Positionen von John Peck
| Unternehmen | Position | Beginn |
|---|---|---|
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 24.02.2017 |
Ausbildung von John Peck
| Northern Illinois University | Undergraduate Degree |
| DePaul University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Health Technology |
